Cargando…
Comparison of biologics and small-molecule drugs in axial spondyloarthritis: a systematic review and network meta-analysis
Background: Biologics and small-molecule drugs have become increasingly accepted worldwide in the treatment of axial spondyloarthritis (axSpA), including ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA). However, a quantitative multiple comparison of their efficacy...
Autores principales: | Zhou, Erye, Wu, Jian, Zeng, Keqin, Wang, Mingjun, Yin, Yufeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628508/ https://www.ncbi.nlm.nih.gov/pubmed/37942485 http://dx.doi.org/10.3389/fphar.2023.1226528 |
Ejemplares similares
-
Efficacy and safety of IL-17 inhibitors for the treatment of ankylosing spondylitis: a systematic review and meta-analysis
por: Yin, Yufeng, et al.
Publicado: (2020) -
Risk of Malignancy and Tuberculosis of Biological and Targeted Drug in Patients With Spondyloarthritis: Systematic Review and Meta-analysis of Randomized Controlled Trials
por: Man, Siliang, et al.
Publicado: (2021) -
Etanercept in axial spondyloarthritis
por: Luo, Gui, et al.
Publicado: (2022) -
Model-Based Meta-Analysis in Psoriasis: A Quantitative Comparison of Biologics and Small Targeted Molecules
por: He, Huan, et al.
Publicado: (2021) -
Predictors of Assessment of Spondyloarthritis International Society (ASAS) Health Index in Axial Spondyloarthritis and Comparison of ASAS Health Index between Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis: Data from the Catholic Axial Spondyloarthritis COhort (CASCO)
por: Min, Hong Ki, et al.
Publicado: (2019)